Personal CFO Solutions’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.48M | Buy |
4,466
+289
| +7% | +$225K | 0.64% | 23 |
|
|
2025
Q1 | $3.45M | Buy |
4,177
+875
| +26% | +$723K | 0.7% | 21 |
|
|
2024
Q4 | $2.55M | Buy |
3,302
+562
| +21% | +$434K | 0.5% | 33 |
|
|
2024
Q3 | $2.43M | Sell |
2,740
-15
| -0.5% | -$13.3K | 0.34% | 59 |
|
|
2024
Q2 | $2.49M | Buy |
2,755
+317
| +13% | +$287K | 0.38% | 51 |
|
|
2024
Q1 | $1.9M | Buy |
2,438
+58
| +2% | +$45.1K | 0.3% | 67 |
|
|
2023
Q4 | $1.39M | Sell |
2,380
-196
| -8% | -$114K | 0.24% | 81 |
|
|
2023
Q3 | $1.38M | Buy |
2,576
+532
| +26% | +$286K | 0.27% | 75 |
|
|
2023
Q2 | $959K | Sell |
2,044
-125
| -6% | -$58.6K | 0.19% | 103 |
|
|
2023
Q1 | $745K | Buy |
2,169
+65
| +3% | +$22.3K | 0.15% | 127 |
|
|
2022
Q4 | $770K | Sell |
2,104
-172
| -8% | -$62.9K | 0.16% | 119 |
|
|
2022
Q3 | $736K | Buy |
2,276
+56
| +3% | +$18.1K | 0.18% | 105 |
|
|
2022
Q2 | $720K | Sell |
2,220
-268
| -11% | -$86.9K | 0.17% | 106 |
|
|
2022
Q1 | $712K | Buy |
2,488
+8
| +0.3% | +$2.29K | 0.14% | 138 |
|
|
2021
Q4 | $685K | Buy |
2,480
+292
| +13% | +$80.7K | 0.13% | 155 |
|
|
2021
Q3 | $506K | Buy |
2,188
+90
| +4% | +$20.8K | 0.1% | 187 |
|
|
2021
Q2 | $482K | Buy |
2,098
+132
| +7% | +$30.3K | 0.1% | 193 |
|
|
2021
Q1 | $367K | Sell |
1,966
-159
| -7% | -$29.7K | 0.08% | 220 |
|
|
2020
Q4 | $359K | Buy |
2,125
+506
| +31% | +$85.5K | 0.09% | 209 |
|
|
2020
Q3 | $0 | Sell |
1,619
-29
| -2% | – | ﹤0.01% | 251 |
|
|
2020
Q2 | $271K | Buy |
+1,648
| New | +$271K | 0.08% | 225 |
|